Viewing Study NCT04601857

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:01 PM
Ignite Modification Date: 2026-05-13 @ 2:54 AM
Study NCT ID: NCT04601857
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-03-04
First Post: 2020-10-15
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Futibatinib and Pembrolizumab Combination in the Treatment of Advanced or Metastatic Urothelial Carcinoma
Sponsor: Taiho Oncology, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced and Metastatic Urothelial Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Futibatinib View
None Pembrolizumab View
None Urothelial cancer View
None FGFR View
None TAS120 View
None MK3475 B04 View